Key Record Dates
ClinicalTrials.gov Identifier: | NCT02160145 |
---|---|
Brief Title: | Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease |
First Submitted : | June 6, 2014 |
First Submitted that Met QC Criteria : | June 6, 2014 |
First Posted : | June 10, 2014 (Estimate) |
Results First Submitted : | May 1, 2018 |
Results First Submitted that Met QC Criteria : | July 13, 2018 |
Results First Posted : | August 8, 2018 |
Certification/Extension First Submitted : | September 18, 2017 |
Certification/Extension First Submitted that Met QC Criteria : | September 18, 2017 |
Certification/Extension First Posted : | September 26, 2017 |
Last Update Submitted that Met QC Criteria : | July 13, 2018 |
Last Update Posted : | August 8, 2018 |